First-in-field combinatorial therapy using anti-tumoral STING agonist to enhance chemotherapy effectiveness for hard-to-cure rhabdomyosarcomas (2025-2026)
Experts
Dr
Cui Tu
Postdoctoral Research Fellow
Frazer Institute
Faculty of Health, Medicine and Behavioural Sciences
